144 related articles for article (PubMed ID: 2811890)
1. Hemiballismus: study of a case using positron emission tomography with 18fluoro-2-deoxyglucose.
Dubinsky RM; Greenberg M; Di Chiro G; Baker M; Hallett M
Mov Disord; 1989; 4(4):310-9. PubMed ID: 2811890
[TBL] [Abstract][Full Text] [Related]
2. Reversible striatal hypermetabolism in a case of Sydenham's chorea.
Goldman S; Amrom D; Szliwowski HB; Detemmerman D; Goldman S; Bidaut LM; Stanus E; Luxen A
Mov Disord; 1993 Jul; 8(3):355-8. PubMed ID: 8341301
[TBL] [Abstract][Full Text] [Related]
3. Cerebral glucose metabolism in the course of subacute sclerosing panencephalitis.
Huber M; Herholz K; Pawlik G; Szelies B; Jürgens R; Heiss WD
Arch Neurol; 1989 Jan; 46(1):97-100. PubMed ID: 2783367
[TBL] [Abstract][Full Text] [Related]
4. [Cerebral glucose metabolism in dementia (PET-FDG study)].
Hatazawa J; Itoh M; Matsuzawa T
Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
[TBL] [Abstract][Full Text] [Related]
5. Regional brain glucose metabolism in neuroacanthocytosis.
Dubinsky RM; Hallett M; Levey R; Di Chiro G
Neurology; 1989 Sep; 39(9):1253-5. PubMed ID: 2788833
[TBL] [Abstract][Full Text] [Related]
6. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study.
Otte A; Weiner SM; Peter HH; Mueller-Brand J; Goetze M; Moser E; Gutfleisch J; Hoegerle S; Juengling FD; Nitzsche EU
Eur J Nucl Med; 1997 Jul; 24(7):787-91. PubMed ID: 9211766
[TBL] [Abstract][Full Text] [Related]
7. Clinical and brain 18fluoro-2-deoxyglucose positron emission tomographic findings in ethylmalonic aciduria, a progressive neurometabolic disease.
al-Essa MA; al-Shamsan LA; Ozand PT
Eur J Paediatr Neurol; 1999; 3(3):125-7. PubMed ID: 10461568
[TBL] [Abstract][Full Text] [Related]
8. Rett syndrome: positron emission tomography (PET) studies.
Wagner HN
Am J Med Genet Suppl; 1986; 1():211-24. PubMed ID: 3087184
[No Abstract] [Full Text] [Related]
9. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
Kuhl DE; Markham CH; Metter EJ; Riege WH; Phelps ME; Mazziotta JC
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():199-209. PubMed ID: 3161165
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
[TBL] [Abstract][Full Text] [Related]
11. Cerebral metabolism of glucose in benign hereditary chorea.
Suchowersky O; Hayden MR; Martin WR; Stoessl AJ; Hildebrand AM; Pate BD
Mov Disord; 1986; 1(1):33-44. PubMed ID: 2973557
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography in a patient with progressive multifocal leukoencephalopathy.
Kiyosawa M; Bosley TM; Alavi A; Gupta N; Rhodes CH; Chawluk J; Kushner M; Savino PJ; Sergott RC; Schatz NJ
Neurology; 1988 Dec; 38(12):1864-7. PubMed ID: 3264059
[TBL] [Abstract][Full Text] [Related]
13. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography study of regional glucose metabolism in cerebral ischemia--topographic and kinetic aspects.
Pawlik G; Wienhard K; Herholz K; Wagner R; Heiss WD
Prog Brain Res; 1984; 62():253-62. PubMed ID: 6335919
[No Abstract] [Full Text] [Related]
15. Positron emission tomography in diagnosing brainstem vascular lesions that cause abnormal eye movements.
Kiyosawa M; Ishii K; Inoue C; Kawasaki T; Senda M
Am J Ophthalmol; 1996 Oct; 122(4):557-67. PubMed ID: 8862054
[TBL] [Abstract][Full Text] [Related]
16. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.
Kuhl DE; Phelps ME; Markham CH; Metter EJ; Riege WH; Winter J
Ann Neurol; 1982 Nov; 12(5):425-34. PubMed ID: 6217782
[TBL] [Abstract][Full Text] [Related]
17. Brain imaging of an alcoholic with MRI, SPECT, and PET.
Wang GJ; Volkow ND; Hitzemann R; Oster ZH; Roque C; Cestaro V
Am J Physiol Imaging; 1992; 7(3-4):194-8. PubMed ID: 1343215
[TBL] [Abstract][Full Text] [Related]
18. Individual metabolic anatomy of repeating words demonstrated by MRI-guided positron emission tomography.
Herholz K; Pietrzyk U; Karbe H; Würker M; Wienhard K; Heiss WD
Neurosci Lett; 1994 Nov; 182(1):47-50. PubMed ID: 7891885
[TBL] [Abstract][Full Text] [Related]
19. F-Dopa as an amino acid tracer to detect brain tumors.
Heiss WD; Wienhard K; Wagner R; Lanfermann H; Thiel A; Herholz K; Pietrzyk U
J Nucl Med; 1996 Jul; 37(7):1180-2. PubMed ID: 8965194
[TBL] [Abstract][Full Text] [Related]
20. Vulnerability to tardive dyskinesia development in schizophrenia: an FDG-PET study of cerebral metabolism.
Szymanski S; Gur RC; Gallacher F; Mozley LH; Gur RE
Neuropsychopharmacology; 1996 Dec; 15(6):567-75. PubMed ID: 8946431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
